Unknown

Dataset Information

0

Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma.


ABSTRACT: We investigated the use of cucurbitacin B, a plant-derived tetracyclic triterpenoid, as a single agent or in combination with methotrexate (MTX) for human osteosarcoma (OS) treatment. Cucurbitacin B showed antiproliferative activity against seven human OS cell lines in vitro accompanying G2/M cell cycle arrest, apoptosis, and inhibition of ERK, Akt, and mTOR proteins. Cucurbitacin B in combination with MTX synergistically inhibited OS cell growth in vitro. Low-dose cucurbitacin B (LD-CuB, 0.5 mg/kg body weight) or low-dose MTX (LD-MTX, 150 mg/kg) failed to decrease the size of human OS xenografts in nude mice. However, combined therapy at identical concentrations inhibited tumor growth by 62% vs. LD-CuB and 81% vs. LD-MTX (p<0.001). Strikingly, the effect persisted even when the dose of MTX was decreased by two thirds (VLD-MTX, 50 mg/kg). In conclusion, cucurbitacin B alone or in combination with MTX shows promising antiproliferative activity against human OS.

SUBMITTER: Lee DH 

PROVIDER: S-EPMC4925102 | biostudies-literature | 2011 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma.

Lee Dhong Hyun DH   Thoennissen Nils H NH   Goff Catherine C   Iwanski Gabriela B GB   Forscher Charles C   Doan Ngan B NB   Said Jonathan W JW   Koeffler H Phillip HP  

Cancer letters 20110326 2


We investigated the use of cucurbitacin B, a plant-derived tetracyclic triterpenoid, as a single agent or in combination with methotrexate (MTX) for human osteosarcoma (OS) treatment. Cucurbitacin B showed antiproliferative activity against seven human OS cell lines in vitro accompanying G2/M cell cycle arrest, apoptosis, and inhibition of ERK, Akt, and mTOR proteins. Cucurbitacin B in combination with MTX synergistically inhibited OS cell growth in vitro. Low-dose cucurbitacin B (LD-CuB, 0.5 mg  ...[more]

Similar Datasets

| S-EPMC4824295 | biostudies-literature
| S-EPMC5354739 | biostudies-literature
| S-EPMC4828529 | biostudies-literature
| S-EPMC3035945 | biostudies-literature
| S-EPMC10278458 | biostudies-literature
| S-EPMC7229518 | biostudies-literature
| S-EPMC6587584 | biostudies-literature
| S-EPMC6761274 | biostudies-literature
| S-EPMC6692531 | biostudies-literature
| S-EPMC7248331 | biostudies-literature